About Sonia Razzetti
Sonia Razzetti is the SVP of Quality with a Ph.D. in Biological Sciences in Public Health from Harvard, known for her expertise in CMC product control strategy, compliance, and operations management.
Known information
Sonia Razzetti currently serves as the Senior Vice President (SVP) of Quality, bringing a robust background in biological sciences and public health, evidenced by her Ph.D. from Harvard Graduate School of Arts and Sciences. She has previously held the role of SVP, Quality and Operations at Generation Bio. Throughout her career, Razzetti has accumulated significant experience in quality roles at several top pharmaceutical companies, including Biogen, Shire, Sanofi, and Ironwood Pharmaceuticals. Her expertise spans CMC product control strategy, compliance, and operations management. Razzetti has played a pivotal role in supporting the development and commercialization of several life-altering therapies such as LINZESS, VPRIV, ELAPRASE, and FIRAZYR.
About Disc Medicine
Disc Medicine develops new therapies for rare blood disorders, focusing on hematologic diseases and conducting clinical trials to evaluate drug efficacy.